Download presentation
Presentation is loading. Please wait.
Published byCorey Poole Modified over 5 years ago
1
Low Incidence of Paravalvular Leakage With the Balloon-Expandable Sapien 3 Transcatheter Heart Valve
Daniel Wendt, MD, Fadi Al-Rashid, MD, Philipp Kahlert, MD, Mareike Eißmann, MD, Karim El-Chilali, MD, Rolf Alexander Jánosi, MD, Susanne Pasa, MD, Konstantinos Tsagakis, MD, Oliver Liakopoulos, MD, Raimund Erbel, MD, Heinz Jakob, MD, Matthias Thielmann, MD The Annals of Thoracic Surgery Volume 100, Issue 3, Pages (September 2015) DOI: /j.athoracsur Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Sapien 3 transcatheter heart valve and Certitude delivery system (Edwards Lifesciences, Irvine, CA). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Changes of mean pressure gradients (MPG, gray line) and aortic valve area (AVA, black line) of patients at risk from baseline to 30 days. The range bars show the standard deviation. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Moderate (green), mild (red), and none or trace (blue) paravalvular aortic regurgitation (AR) at 30 days. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
5
Fig 4 Survival after transcatheter aortic valve replacement (TAVR) with the Sapien 3 transcatheter heart valve (Edwards Lifesciences, Irvine, CA) for the total cohort (n = 54). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.